Handok Pharmaceuticals Co., Ltd. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Handok Pharmaceuticals Co., Ltd.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Handok Pharmaceuticals Co., Ltd.. The Company's principal activities are manufacturing and distributing over-the-counter medicines. The Company's products include Amaryl for diabetes, Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular disease, Teveten for essential hypertension, Festal for dyspepsia, Munobal for hypertension and stenocardia, Triapin for essential hypertension, Gatiflo for respiratory and other infective disease, Lasix for hypertension and edema, Ketas for disturbance of cerebral circulation and Dermatop for dermatology. In addition, the Company offers reagents and diagnostic instruments. It is also engaged in the real estate leasing business. The Company operates a research laboratory in Seoul and a plant in Chungcheongbuk-Do, Korea.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report